ad image

Company Info

Alcami

Alcami

CDMO

Overview

Alcami is a contract development and manufacturing organization headquartered in North Carolina with over 40 years of experience advancing products through every stage of the development lifecycle. Leveraging four US-based scientific campuses, Alcami serves biologics and pharmaceutical companies of all sizes providing customizable and innovative solutions for development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, and analytical services. Alcami's private equity owners include Madison Dearborn Partners and Ampersand Capital Partners. For more information, please visit alcaminow.commdcp.com, or ampersandcapital.com
Alcami
Contributions
22 Contributions1 / 2
Alcami
New cGMP Facility

Alcami Builds cGMP Biostorage Facility in North Carolina

Alcami

PR-M12-22-01Dec 01, 2022
Alcami
Facility Expansion

Alcami Expands Biopharma Storage at Masy BioServices

Alcami

PR-M03-22-15Mar 29, 2022
Alcami
FDA Approval

Alcami Helps Medicines Development for Global Health Secure FDA Approval of Moxidectin for River Blindness

Alcami

PR-M10-18-NI-095Oct 29, 2018
Aligning with Sponsors for Strategic Growth
Investment

Aligning with Sponsors for Strategic Growth

Syed T. Husain; Catherine Hanley

Alcami

PAP-Q3-18-CL-014Oct 02, 2018
Alcami
Commercial Supply

Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)

Alcami

PR-M06-18-NI-047Jun 13, 2018
Alcami
Acquisition

Alcami to Become Industry Leading Platform CDMO Following Acquisition by Madison Dearborn Partners

Alcami

PR-M06-18-NI-021Jun 04, 2018
Alcami
Announcement

Alcami St. Louis Facility to be Honored by Missouri House of Representatives and City of St. Louis

Alcami

PR-M05-18-NI-032May 09, 2018
Alcami
Donation

Alcami Donation to Outfit TROSA Medical Department

Alcami

PR-M03-18-NI-065Mar 19, 2018
Driving Change in the Pharma Industry and Biotech One Relationship at a Time
Strategic Collaboration

Driving Change in the Pharma Industry and Biotech One Relationship at a Time

Syed T. Husain; Catherine Hanley

Alcami

PAP-Q1-18-CL-004-4589Mar 12, 2018
Alcami
Growth

Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA

Alcami

PR-M02-18-NI-63Feb 14, 2018
Right-First-Time Innovation Approach Drives Continual Investment
API

Right-First-Time Innovation Approach Drives Continual Investment

Adam Kujath

Alcami

PAP-Q4-17-CL-003Oct 26, 2017
Alcami
Facility

Alcami Announces Grand Opening of St. Louis, Missouri Facility In Cortex Innovation Community

Alcami

PR-M09-17-NI-003-5174Sep 18, 2017
Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations
Abuse Deterrence

Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations

Angela Moore, M.Sc.

Alcami

PAP-Q3-17-CL-003Sep 15, 2017
Alcami on the Road to BIO: Creating Differentiated Value For Biotechs
Serialization

Alcami on the Road to BIO: Creating Differentiated Value For Biotechs

Natasha Howard

Alcami

PTV-M06-17-CL-009Jun 21, 2017
Implications of Serialization for the U.S. Pharma Industry
Regulatory

Implications of Serialization for the U.S. Pharma Industry

Walter C. Holberg III; Lee Murtagh

Alcami

PAP-Q2-17-CL-001Jun 05, 2017
Supporting the Pharma Industry Small Business Growth Engine

Supporting the Pharma Industry Small Business Growth Engine

Syed T. Husain; Catherine Hanley

Alcami

PAP-Q1-17-CL-017Mar 08, 2017
Keys to Cultural Integration

Keys to Cultural Integration

Nigel Walker; Catherine Hanley

Nice Insight

PAP-Q1-17-QA-001Mar 08, 2017
Supply Chain Management and the Importance of Security of Supply

Supply Chain Management and the Importance of Security of Supply

Syed T. Husain

Alcami

PAP-Q04-16-CL-002Oct 01, 2016
Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience
Formulation

Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience

Syed T. Husain

Alcami

PAP-Q03-16-CL-005Aug 01, 2016
Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals

Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals

Syed T. Husain

Alcami

PAP-Q02-16-CL-011Apr 01, 2016
1 / 2